{
    "organizations": [],
    "uuid": "f1fd202fb3aea161b9cc40a5d9dc69672f54c2ca",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-kubota-pharmaceutical-holdings-uni/brief-kubota-pharmaceutical-holdings-unit-and-sirion-biotech-set-sights-on-gene-delivery-tools-for-ocular-gene-therapy-idUSL4N1P41HD",
    "ord_in_thread": 0,
    "title": "BRIEF-Kubota Pharmaceutical Holdings unit and SIRION Biotech set sights on gene delivery tools for ocular gene therapy",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 9 (Reuters) - Kubota Pharmaceutical Holdings Co Ltd\n* Says coâ€™s wholly owned unit Acucela Inc signed a two-year development agreement with gene delivery expert SIRION Biotech GmbH (SIRION) to establish optimized AAV vectors for clinical applications in ocular gene therapy\n* Says Acucela bolsters its move into the fast growing gene therapy market to find a genetic cure for retinitis pigmentosa\n* Key terms of the agreement include milestone payments to SIRION, with additional royalties to be paid on net sales from resulting products or therapies\nSource text in Japanese: goo.gl/n8VbQu\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-01-09T10:31:00.000+02:00",
    "crawled": "2018-01-09T17:05:52.056+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "kubota",
        "pharmaceutical",
        "holding",
        "co",
        "ltd",
        "say",
        "co",
        "wholly",
        "owned",
        "unit",
        "acucela",
        "inc",
        "signed",
        "development",
        "agreement",
        "gene",
        "delivery",
        "expert",
        "sirion",
        "biotech",
        "gmbh",
        "sirion",
        "establish",
        "optimized",
        "aav",
        "vector",
        "clinical",
        "application",
        "ocular",
        "gene",
        "therapy",
        "say",
        "acucela",
        "bolster",
        "move",
        "fast",
        "growing",
        "gene",
        "therapy",
        "market",
        "find",
        "genetic",
        "cure",
        "retinitis",
        "pigmentosa",
        "key",
        "term",
        "agreement",
        "include",
        "milestone",
        "payment",
        "sirion",
        "additional",
        "royalty",
        "paid",
        "net",
        "sale",
        "resulting",
        "product",
        "therapy",
        "source",
        "text",
        "japanese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}